NWP06, an extended-release oral suspension of methylphenidate, improved attention-deficit/hyperactivity disorder symptoms compared with placebo in a laboratory classroom study.


OBJECTIVE The purpose of this study was to determine the efficacy of NWP06, a novel extended-release (ER) liquid formulation of methylphenidate (MPH), compared with placebo in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children in a laboratory school. METHODS A total of 45 subjects ages 6-12 years were enrolled in this dose… (More)
DOI: 10.1089/cap.2012.0073


  • Presentations referencing similar topics